July 14, 2014

Mylan will acquire Abbott's non-U.S. developed markets specialty and branded generics business.

May 16, 2014

Abbott announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence the company reported.

November 8, 2013

Creating a home destination center for diabetic patients stocked with products appropriate to their condition —not only including sugar tablets, gels and liquids, but also nutritional supplements, homeopathic products, skin creams and lotions, oral care solutions, pain relief products and hypoglycemic products — has gained in importance thanks to the price pressures associated with competitive bidding in the diabetes space.

February 12, 2013

According to a national survey of fitness enthusiasts who exercise three or more times a week, 82% admitted to falling short when it comes to post-workout nutrition habits, Abbott announced.

January 8, 2013

Abbott Labs has spun off its specialty drug division into a new company called AbbVie, which the new company's leaders heralded Wednesday by ringing the first opening bell of 2013 at the New York Stock Exchange.

November 13, 2012

Patients with a form of arthritis that affects young people taking a drug made by Abbott experienced improvements in their condition after a year of treatment, according to late-stage clinical trial results.

September 12, 2012

Abbott on Wednesday launched Drive for Five, a multifaceted, disease education and men's health awareness initiative, to encourage men to take a more proactive approach to their personal health.

July 16, 2012

Several policy-makers and companies have sought ways to confront the problem of prescription drug abuse. Last month, New York Gov. Andrew Cuomo announced a plan — calling it the first in the country — to create an all-
electronic registry that would enable doctors, pharmacists and law enforcement to track controlled substances to prevent excessive prescription and refill requests.

June 26, 2012

Abbott's ZonePerfect brand has introduced a new line of nutrition bars.

June 6, 2012

Abbott on Tuesday announced the launch of Ensure Clear, a nutrition beverage available in peach and blueberry pomegranate flavors that offers three times more protein than juice, according to the company, and 21 vitamins and minerals to help adults looking to fill dietary gaps.

May 16, 2012

Abbott on Wednesday launched PediaSure SideKicks Clear, a clear nutritional beverage that helps balance out the diet of picky eaters who may be missing nutrients.

April 30, 2012

Abbott recently launched Perfectly Simple by ZonePerfect, a line extension that is gluten-free and features fewer ingredients in each bar (between six and 10 ingredients).

April 25, 2012

Abbott on Wednesday announced that its EAS sports nutrition brand has launched a new line of performance nutrition products.

March 19, 2012

Watson Pharmaceuticals is challenging the patent protection on a drug made by Abbott for treating cholesterol, the company said.

March 15, 2012

Abbott is set to enroll patients into two late-stage clinical trials designed to evaluate the safety and efficacy of one of its drugs as a treatment for a difficult-to-treat chronic inflammatory skin disease.

March 8, 2012

A blood-glucose monitoring system created by Abbott has received clearance from the Food and Drug Administration.

February 9, 2012

The National Association for Female Executives on Wednesday released its list of the "Top 50 Companies for Executive Women."

February 8, 2012

Abbott has introduced a new BPA-free baby bottle, which includes several innovative features that are designed to improve the bottle-feeding experience.

January 3, 2012

Mylan has launched a generic drug for treating high blood pressure, the company said.

January 3, 2012

The market for meal replacement ready-to-drink shakes is expanding beyond the need for a shake-shake-sensible-meal diet plan, or the need for a protein booster, with a number of niche marketing opportunities.


December 20, 2011

The market for drugs to treat ulcerative colitis will increase from 2010's $1.7 billion to $3 billion in 2020, according to a new report by market research firm Decision Resources.

November 7, 2011

A large number of patients with a serious form of arthritis experienced improvement in their condition after taking a drug made by Abbott Labs for three months, according to results of a late-stage clinical trial announced Monday.

November 2, 2011

Drug maker Perrigo has filed for regulatory approval of a generic topical drug for treating testosterone deficiency, prompting a patent infringement suit from the branded version's manufacturer.

November 2, 2011

Abbott last week officially announced the launch of Glucerna Hunger Smart nutrition shakes, pictured here at a central Pennsylvania Wegmans, that specifically targets patients living with diabetes.